|Articles|August 26, 2019
Antibody Drug Conjugate Purification Using TOYOPEARL® PPG-600M Resin
Author(s)Tosoh Bioscience LLC
In this application note, antibody drug conjugates (ADCs) were separated into groups with low, medium, and high drug-to-antibody ratios (DARs) using TOYOPEARL PPG-600M resin with a three-step gradient.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
2
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
3
Conjugation and Regulation Challenges for Advanced Molecules: Part Two of Three with Abzena
4
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
5